WordNet
- a complex consisting of an organic base in association with hydrogen chloride
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/06/05 22:23:21」(JST)
wiki en
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 慢性腎疾患における高リン血症の治療 treatment of hyperphosphatemia in chronic kidney disease
- 2. 慢性腎臓病における血管石灰化 vascular calcification in chronic kidney disease
- 3. 腎不全における炎症 inflammation in renal insufficiency
- 4. 尿毒症毒素 uremic toxins
- 5. 急性腎障害（急性腎不全）のマネージメントの概要 overview of the management of acute kidney injury acute renal failure
English Journal
- Subtherapeutic serum quetiapine concentrations after absorption inhibition by binding resins: a case report.
- Hoge RH1, Arbouw ME, Radstake SD, van Berlo-van de Laar IR.
- Journal of clinical pharmacy and therapeutics.J Clin Pharm Ther.2015 Jun;40(3):355-7. doi: 10.1111/jcpt.12265. Epub 2015 Mar 25.
- WHAT IS KNOWN AND OBJECTIVE: Polystyrene sulfonate and sevelamer are binding resins that are used in the treatment of, respectively, hyperkalemia and hyperphosphatemia. It is unknown whether these resins interact with the antipsychotic quetiapine.CASE SUMMARY: We report on a woman with unexplainable
- PMID 25808008
- Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.
- Floege J1, Covic AC2, Ketteler M3, Mann JF4, Rastogi A5, Spinowitz B6, Chong EM7, Gaillard S7, Lisk LJ7, Sprague SM8; Sucroferric Oxyhydroxide Study Group.
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.Nephrol Dial Transplant.2015 Jun;30(6):1037-46. doi: 10.1093/ndt/gfv006. Epub 2015 Feb 16.
- BACKGROUND: Hyperphosphatemia necessitates the use of phosphate binders in most dialysis patients. Long-term efficacy and tolerability of the iron-based phosphate binder, sucroferric oxyhydroxide (previously known as PA21), was compared with that of sevelamer carbonate (sevelamer) in an open-label P
- PMID 25691681
- Oral peptide specific egg antibody to intestinal sodium-dependent phosphate co-transporter-2b is effective at altering phosphate transport in vitro and in vivo 1.
- Bobeck EA1, Hellestad EM1, Sand JM1, Piccione ML1, Bishop JW1, Helvig C2, Petkovich M3, Cook ME4.
- Poultry science.Poult Sci.2015 Jun 1;94(6):1128-37. doi: 10.3382/ps/pev085. Epub 2015 Mar 29.
- Hyperimmunized hens are an effective means of generating large quantities of antigen specific egg antibodies that have use as oral supplements. In this study, we attempted to create a peptide specific antibody that produced outcomes similar to those of the human pharmaceutical, sevelamer HCl, used i
- PMID 25825784
Japanese Journal
- 塩酸セベラマーの長期投与が血液透析患者の動脈硬化, 脂質代謝に与える影響について
- 日本透析医学会雑誌 48(1), 51-56, 2015
- NAID 130004880121
- 二次性副甲状腺機能亢進症を合併した透析患者の副甲状腺摘出術において術中intact PTHモニタリングを行った1例
- 日本透析医学会雑誌 47(8), 493-499, 2014
- NAID 130004685519
- Effect of switching from sevelamer hydrochloride to lanthanum carbonate on metabolic acidosis in dialysis patients
- Acta Medica Nagasakiensia 58(3), 79-84, 2013-12
- NAID 110009662225
Related Links
- Renagel - Tablets (as hydrochloride) 400 mg - Tablets (as hydrochloride) 800 mg Renvela - Tablets (as carbonate) 800 mg - Suspension, oral (as carbonate) 0.8 g per packet - Suspension, oral (as carbonate) 2.4 g per packet
- Sevelamer HCl | C6H13Cl2NO | CID 159247 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more. NIH ...
Related Pictures
★リンクテーブル★
| リンク元 | 「セベラマー」「RENAGEL」 |
| 関連記事 | 「hydrochloride」 |